Search Results - "Everson, G T"

Electrochemical Biosensors in Point‐of‐Care Devices: Recent Advances and Future Trends by da Silva, Everson T. S. G., Souto, Dênio E. P., Barragan, José T. C., de F. Giarola, Juliana, de Moraes, Ana C. M., Kubota, Lauro T.

“…The use of biosensors in point‐of‐care (POC) testing devices has attracted considerable attention in the past few years, mainly because of their high…”
Get full text

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database by Reddy, K. R., Lim, J. K., Kuo, A., Di Bisceglie, A. M., Galati, J. S., Morelli, G., Everson, G. T., Kwo, P. Y., Brown, R. S., Sulkowski, M. S., Akuschevich, L., Lok, A. S., Pockros, P. J., Vainorius, M., Terrault, N. A., Nelson, D. R., Fried, M. W., Manns, M. P.

“…Summary Background Chronic hepatitis C virus therapy in patients with advanced liver disease remains a clinical challenge. HCV‐TARGET collects data in patients…”
Get full text

Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort by Kulik, L. M., Fisher, R. A., Rodrigo, D. R., Brown, Jr, R. S., Freise, C. E., Shaked, A., Everhart, J. E., Everson, G. T., Hong, J. C., Hayashi, P. H., Berg, C. L., Lok, A. S. F.

“…Hepatocellular carcinoma (HCC) represents an increasing fraction of liver transplant indications; the role of living donor liver transplant (LDLT) remains…”
Get full text

Insight into the Electro-Oxidation Mechanism of Glucose and Other Carbohydrates by CuO-Based Electrodes by Barragan, José T. C, Kogikoski, Sergio, da Silva, Everson T. S. G, Kubota, Lauro T

“…In this work, a new hypothesis for the electrocatalytic behavior of CuO electrodes is presented. Different from the established mechanism, here we discuss why…”
Get full text

Histological benefits of virological response to peginterferon alfa‐2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis by EVERSON, G. T., BALART, L., LEE, S. S., REINDOLLAR, R. W., SHIFFMAN, M. L., MINUK, G. Y., POCKROS, P. J., GOVINDARAJAN, S., LENTZ, E., HEATHCOTE, E. J.

“…Summary Background  Patients with chronic hepatitis C virus and advanced fibrosis or cirrhosis are at risk for disease progression and hepatic decompensation…”
Get full text

Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT‐C trial by EVERSON, G. T., SHIFFMAN, M. L., HOEFS, J. C., MORGAN, T. R., STERLING, R. K., WAGNER, D. A., DESANTO, J. L., CURTO, T. M., WRIGHT, E. C.

“…Summary Backgroud  The impact of virologic response on hepatic function has not been previously defined. Aim  To determine the relationships of quantitative…”
Get full text

Laparoscopic palliation of polycystic liver disease by ROBINSON, T. N, STIEGMANN, G. V, EVERSON, G. T

“…The role of laparoscopic surgery in the management of polycystic liver disease (PCLD) is not well defined. The authors hypothesized that laparoscopic…”
Get full text

Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension by Afdhal, N., Everson, G. T., Calleja, J. L., McCaughan, G. W., Bosch, J., Brainard, D. M., McHutchison, J. G., De‐Oertel, S., An, D., Charlton, M., Reddy, K. R., Asselah, T., Gane, E., Curry, M. P., Forns, X.

“…Summary Portal hypertension is a predictor of liver‐related clinical events and mortality in patients with hepatitis C and cirrhosis. The effect of…”
Get full text

Triboelectric effect as a new strategy for sealing and controlling the flow in paper-based devices by da Silva, Everson T S G, Santhiago, Murilo, de Souza, Fabrício R, Coltro, Wendell K T, Kubota, Lauro T

“…We reported here for the first time that triboelectric charges on PET sheets can be used to seal and control the flow rate in paper-based devices. The proposed…”
Get more information

The spectrum of hepatic functional impairment in compensated chronic hepatitis C : results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial by EVERSON, G. T, SHIFFMAN, M. L, MORGAN, T. R, HOEFS, J. C, STERLING, R. K, WAGNER, D. A, KULIG, C. C, CURTO, T. M, WRIGHT, E. C

“…The spectrum of functional impairment in patients with compensated chronic hepatitis C is incompletely defined. To define hepatic impairment by quantitative…”
Get full text

Portal‐systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt by EVERSON, G. T., MARTUCCI, M. A., SHIFFMAN, M. L., STERLING, R. K., MORGAN, T. R., HOEFS, J. C.

“…Summary Background  Measurement of portal inflow and portal‐systemic shunt using cholate clearances could be useful in monitoring patients with liver disease…”
Get full text

Adult living donor liver transplantation using a right hepatic lobe by WACHS, M. E, BAK, T. E, KARRER, F. M, EVERSON, G. T, SHRESTHA, R, TROUILLOT, T. E, MANDELL, M. S, STEINBERG, T. G, KAM, I

“…Living donor liver transplantation has gained wide acceptance as an alternative for children with end-stage liver disease. The standard left lateral segment…”
Get full text

Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for transjugular intrahepatic portosystemic shunt (TIPS) by TROTTER, J, PIERAMICI, E, EVERSON, G. T

“…While transjugular intrahepatic portosystemic shunt (TIPS) is a common therapy for cirrhotic patients with diuretic-resistant or diuretic-refractory ascites,…”
Get full text

Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease by Sherstha, R, McKinley, C, Russ, P, Scherzinger, A, Bronner, T, Showalter, R, Everson, G T

“…The goal of this study was to determine whether use of postmenopausal estrogen (Premarin®, Wyeth‐Ayerst, Philadelphia, PA) in women with autosomal dominant…”
Get full text

Clinical trial: interferon alpha‐2b continuous long‐term therapy vs. repeated 24‐week cycles for re‐treating chronic hepatitis C by MCHUTCHISON, J. G., PATEL, K., SCHIFF, E. R., GITLIN, N., MUR, R. E., EVERSON, G. T., CARITHERS, R. L., DAVIS, G. L., MARCELLIN, P., SHIFFMAN, M. L., HARVEY, J., ALBRECHT, J. K.

“…Summary Background  Treatment options are limited for patients with hepatitis C virus who do not experience sustained viral eradication with pegylated…”
Get full text

Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss by Stegall, M. D., Everson, G. T., Schroter, G., Karrer, F., Bilir, B., Sternberg, T., Shrestha, R., Wachs, M., Kam, I.

“…We prospectively withdrew prednisone in 28 adult patients who had stable graft function more than 2 years after orthotopic liver transplantation (OLTx) and had…”
Get full text

Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients by STEPHENS, J. K, EVERSON, G. T, ELLIOTT, C. L, KAM, I, WACHS, M, HANEY, J, BARTLETT, S. T, FRANKLIN, W. A

“…In this report we describe the transfer of malignant melanoma from a single donor to four solid organ transplant recipients, all of whom died from metastatic…”
Get full text

Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics by Everson, Gregory T., Jensen, Donald M., Craig, John R., van Leeuwen, Dirk J., Bain, Vincent G., Ehrinpreis, Murray N., Albert, Donald, Joh, Tenshang, Witt, Karsten

“…Chronic hepatitis C patients (472 patients) were treated with consensus interferon (CIFN) or interferon (IFN) alfa‐2b for 6 months in a large multicenter…”
Get full text

Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis by Trouillot, Thomas E., Shrestha, Roshan, Kam, Igal, Wachs, Michael, Everson, Gregory T.

“…Corticosteroid withdrawal after orthotopic liver transplantation (OLT) represents an attractive therapeutic option for ameliorating post‐OLT metabolic…”
Get full text

Effects of psyllium hydrophilic mucilloid on LDL-cholesterol and bile acid synthesis in hypercholesterolemic men by Everson, GT, Daggy, BP, McKinley, C, Story, JA

“…The goal of the current study was to determine the mechanism of the hypocholesterolemic effect of psyllium using a randomized, double-blind, crossover design…”
Get full text